It is not known in detail whether postprandial lipaemia is associated with coronary artery disease (CAD) in women. To investigate this, we administered an oral vitamin A/squalene/fat meal to 24 post-menopausal women with angiographically proven CAD who were not taking hormone replacement therapy, and to 30 healthy controls (18 without and 12 with hormone replacement therapy) to evaluate the effects of CAD on postprandial lipoprotein metabolism. This was done by assessing squalene, triacylglycerols, retinyl palmitate and apolipoprotein B-48 (apoB-48) during the subsequent 24 h. The subjects with CAD had significantly higher fasting concentrations of squalene and apoB-48 in triacylglycerol-rich lipoproteins (TGRL) compared with the controls. The postprandial areas under the incremental curve of TGRL apoB-48, chylomicrons, very-low-density lipoprotein (VLDL) and TGRL squalene, and of retinyl palmitate in VLDL only, were significantly higher in women with CAD than in controls. Adjustment for fasting values did not eliminate the differences in postprandial squalene and apoB-48 between CAD and controls. The postprandial responses of control subjects were not influenced by hormone replacement therapy. The peaks of squalene and retinyl palmitate of the controls, but not of the women with CAD, occurred significantly earlier (P 0.01 for both) in chylomicrons than in VLDL. The findings suggest that lipoproteins that accumulate postprandially are labelled by dietary squalene, and that these lipoproteins may be atherogenic in post-menopausal women.
INTRODUCTION
Since humans spend a considerable portion of time in a postprandial state, postprandial lipoproteins could have an impact on atherogenesis [1, 2] . The temporary accumulation of chylomicrons and chylomicron remnants in the postprandial state may lead to lipid deposition into the arterial wall and macrophages [3, 4] . It has been documented in several studies that men with coronary artery disease (CAD) have pronounced postprandial lipaemia in comparison with healthy controls [5] [6] [7] [8] [9] [10] [11] [12] [13] . Although men and women are postulated to have different postprandial lipoprotein metabolism [14] , there is only one previous study that focused on women with CAD in a postprandial state [15] . The women with CAD had higher postprandial concentrations of intermediatedensity lipoprotein (IDL) than women with valvular heart disease serving as controls. On the other hand, in another study, women with angina only, without a history of myocardial infarction, showed no accumulation of postprandial lipoproteins [12] . Accordingly, the question of whether pronounced postprandial lipaemia is associated with coronary atherosclerosis in women, as it is in men, has not been answered in detail.
The vitamin A fat-loading test has been used frequently to label postprandial lipoproteins. Since retinyl palmitate is also found in lipoproteins other than chylomicrons and chylomicron remnants during the later stages of the postprandial phase, apolipoprotein B-48 (apoB-48) was suggested as a more specific indicator of lipoproteins that originate intestinally [16] . The quantification of apoB-48 is laborious, and therefore searches have been made for other postprandial markers. Squalene is a triterpenoid hydrocarbon intermediate of cholesterol biosynthesis, which in the fasting state is mainly associated with lowdensity lipoprotein (LDL) in the circulation [17] . Dietary squalene, similarly to vitamin A, is incorporated into chylomicrons and chylomicron remnants [18] . Elevation of squalene levels in chylomicrons and chylomicron remnants following a squalene\vitamin A mixed-fat meal suggested that squalene is also a marker of intestinal lipoproteins [19] . The postprandial metabolism of squalene in women with CAD has not been elucidated.
Accordingly, the aim of the present study was to investigate the postprandial metabolism of lipoproteins and squalene in post-menopausal women with angiographically proven CAD, and in controls matched for age and body mass index, by assessing postprandial responses of triacylglycerols, squalene, retinyl palmitate and apoB-48.
Part of this work was presented at the 11th International Symposium on Atherosclerosis, Paris, France, October 5-9, 1997.
METHODS

Subjects
A total of 24 post-menopausal women aged 50-55 years and with a positive coronary angiography were recruited from the University Central Hospital of Helsinki. Twelve of them had suffered from a myocardial infarction, nine had undergone coronary artery bypass surgery, and 13 had undergone percutaneous transluminal angioplasty, all at least 6 months before entry into the study. None of the patients had congestive cardiac failure, renal, thyroid or hepatic diseases, or diabetes mellitus, or suffered from extreme obesity (body mass index 30 kg\m#), or were taking hormone replacement therapy or hypolipidaemic medication. Beta-blocking agents were used by 15 patients, and angiotensin-converting enzyme inhibitor by one.
The healthy control group was selected randomly from the population register of 50-and 55-year-old women living in Helsinki. A total of 30 women that were not taking hypolipidaemic treatment, without a history of chest pain, with a normal electrocardiogram, and with a body mass index of 30 kg\m# participated in the study. Seven of them were hypertensive ; three were treated with beta-blockers, two with angiotensin-converting enzyme inhibitors and two with thiazide. Of the control women, 18 were not taking hormone replacement therapy, whereas two used transdermal oestrogen, eight used peroral combined oestrogen and progestin, and two used progestin alone.
The post-menopausal state was demonstrated by amenorrhoea and elevated serum follicle-stimulating hormone levels ( 30 units\litre). All subjects volunteered for the study, and gave informed consent. The study protocol followed the ethical principles of the Declaration of Helsinki, and was approved by the Ethics Committee of our institution.
Oral vitamin A/squalene/fat tolerance test
After a 12 h fast, a blood sample was drawn to obtain baseline values. The participants were then given a test meal containing 200 ml of 38 % cream, an egg yolk, 345 000 i.u. of vitamin A and 0.5 g of squalene. This meal consisted of 90 g of fat, 432 mg of cholesterol and 50 20 kJ (1200 kcal) of energy. During the 24 h period following the meal, the subjects fasted except for a routine hospital meal after 9 h. Blood samples were taken at 3, 4, 6, 9, 12 and 24 h. The subjects were then advised to continue with their normal diets, and dietary fat and cholesterol were calculated from 7-day dietary recalls [20] .
Lipoprotein fractionation
Lipoproteins from fasting sera were separated by ultracentrifugation in a fixed-angle Ti 50. 4 Chylomicrons were isolated by aspirating the top 3.6 ml. The infranatant was then mixed with the 1.006 g\ml NaCl solution and centrifuged at 131 849 g (35 000 rev.\ min) for 18 h to separate VLDL. Another aliquot of 3.0-3.5 ml of plasma was overlayered with NaCl solution of density 1.006 g\ml and ultracentrifuged at 131 849 g for 18 h. A combination of chylomicrons and VLDL, defined as the triacylglycerol-rich lipoprotein (TGRL) fraction, was recovered in the top 0.5 ml.
Assay of apoB-48
The method, described previously [21] , was modified to assess apoB-48 in the TGRL fraction at baseline and at 4, 6, 9 and 24 h postprandially. Isolated LDL apoB-100 was used as a standard for apoB-48. Lipoprotein preparations were dialysed overnight at 4 mC against 0.15 mol\l NaCl in 1 mmol\l EDTA, pH 7.4. The apolipoprotein mass of the LDL fraction was determined by the Lowry procedure, with BSA (Sigma) as standard [22] . The dialysed LDL and TGRL fractions, each containing 60-200 µg of protein, were delipidated with ice-cold ethanol\diethyl ether (3 : 1, v\v) and centrifuged to precipitate apolipoproteins [23] . The protein sediment was then resolubilized in sample buffer containing 0.5 mol\l Tris, 0.15 mol\l sodium phosphate, 10 % (w\v) SDS, 87 % (v\v) glycerol, 1.12 g\ml 2-mercaptoethanol and 0.05 % Bromophenol Blue, and denatured at 80 mC for 10 min. The apoB-100 standard (0.1-1.0 µg of protein) and TGRL fractions were applied on to two 2-14 % (w\v) polyacrylamide gradient gels in the presence of SDS in a MiniProtean II vertical gel apparatus (Bio-Rad), and run simultaneously at 90 V for 10 min and then at 200 V for 60 min. The gels were stained with 0.04 % Coomassie Blue G-250 and destained with 5 % acetic acid. They were scanned using a CliniScan 2 densitometer (Helena Laboratories), and the area under each peak was integrated to obtain the absorbance. The linear regression line between the absorbance and the known LDL apoB-100 mass was used to calculate the apoB-48 concentration in the TGRL fraction. ApoB-100 was not measured in the TGRL fraction, as it needs extra gel application of 10-20-fold diluted samples.
Lipid and apolipoprotein analyses
Cholesterol and triacylglycerols were quantified using commercial kits (Boehringer Diagnostica). ApoB was assayed immunoturbidimetrically with anti-(human apoB) antiserum using a commercial kit (Orion Diagnostica, Espoo, Finland). ApoE phenotypes were determined by isoelectric focusing [24] . Retinyl palmitate was quantified by HPLC using a normal-phase LC-Si column (Supelcosil ; 250 mmi4.6 mm) at 326 nm [25] . Squalene was quantified by GLC using a Hewlett Packard Ultra I column (50 m long) [26] .
Data analysis
Continuous values are expressed as meanspS.E.M. Responses to the fat meal were characterized in terms of area under the incremental curve (AUIC) and incremental peak concentration (PIC). AUIC was calculated by the trapezoidal method for 24 h curves. All postprandial triacylglycerol and apoB-48 concentrations were below baseline levels at 9 h, so that 9 h AUICs were calculated for these parameters. PIC is defined as the difference between the baseline concentration and the highest postprandial concentration observed.
Statistical analysis was performed using the BMDP statistical computer software package. Differences between continuous variables were tested using Student's two-tailed t-test and the Mann-Whitney rank sums test ; those between discrete variables with the Chi-square test and Fisher's exact probability test ; and those between postprandial concentrations and 24 h curves by analysis of variance for repeated measures. Analysis of covariance was used to calculate AUICs adjusted for baseline parameters. Spearman's rank correlation coefficients were calculated. A P value of 0.05 was considered significant.
RESULTS
Baseline characteristics
The mean age, body mass index, blood pressure, apoE phenotype distribution, frequency of smokers, and dietary fat and cholesterol intakes were comparable in the two groups ( Table 1 ). The patients with CAD used betablockers more frequently than the control subjects. The only differences between baseline lipids and lipoproteins were the higher concentrations of LDL cholesterol, squalene in serum, TGRL and d 1.006 lipoproteins, and TGRL apoB-48 in the women with CAD compared with the controls. Curves and concentrations were significantly different for TGRL squalene (F l 2.50, P l 0.022 and F l 8.33, P l 0.006 respectively) and TGRL apoB-48 (F l 8.25, P 0.000 and F l 16.8, P 0.000 respectively) in the women with CAD compared with controls (as calculated by analysis of variance for repeated measures).
Postprandial responses
Triacylglycerols
The triacylglycerol concentrations, 9 h AUICs and PIC for TGRL, chylomicrons, VLDL and d 1.006 lipoproteins were similar in the CAD and control subjects (Figures 1 and 2 ; Table 2 ).
Squalene
The average concentrations and the 24 h curves for squalene were higher in the TGRL (F l 8.33, P l 0.006 and F l 2.50, P l 0.022 respectively ; Figure 1 ), chylomicron (F l 6.01, P l 0.017 and F l 2.07, P l 0.056 respectively) and VLDL (F l 8.22, P l 0.006 and F l 2.37, P l 0.029 respectively) fractions of the women with CAD compared with the control group (Figure 2 Concentrations and curves were different for chylomicron squalene (F l 6.01, P l 0.017 and F l 2.07, P l 0.056 respectively) and VLDL squalene (F l 8.22, P l 0.006 and F l 2.37, P l 0.029 respectively) in the women with CAD compared with controls (as calculated by analysis of variance for repeated measures).
1.006 lipoproteins peaked at about 9 h, and subsequently returned to basal values at 24 h (Figure 1) , with similar AUICs in the two groups. The time to peak squalene concentration was significantly shorter in chylomicrons (6.97p0.36 h) than in VLDL (8.63p0.46 h) in the healthy controls only (P 0.01). The squalene\triacylglycerol ratio was clearly higher in chylomicrons than in VLDL throughout the 24 h period in both groups ( Table 3 ). The ratios in chylomicrons and VLDL at 24 h were significantly higher in the women with CAD than in controls.
Retinyl palmitate
Postprandial retinyl palmitate concentrations, AUICs and PIC in the TGRL, chylomicron and d 1.006 lipoprotein fractions were similar, but the AUICs and PIC for the VLDL fraction were significantly higher in the CAD patients compared with the controls (Figures 1   and 2 ; Table 2 ). The concentration peaked significantly earlier in chylomicrons than in VLDL (6.10p0.28 and 8.06p0.50 h respectively ; P 0.01) in the control subjects only, and peaked at about 12 h in d 1.006 lipoproteins in both groups (Figure 1) . Furthermore, incremental 24 h retinyl palmitate concentrations in d 1.006 lipoproteins were increased in both the CAD (j24.7p2.8 µg\l; P 0.0001) and control (j30.4 p2.1 µg\l; P 0.0001) groups, despite normalization of the squalene concentration at this time. The retinyl palmitate\triacylglycerol ratio was consistently higher in chylomicrons than in VLDL throughout the postprandial period, and at 3 h was higher in the controls than in women with CAD (Table 3) .
TGRL apoB-48
The TGRL apoB-48 concentration (F l 16.8, P 0.000), especially at 6 h (2.63p0.63 and 1.21p0.25 mg\l re- spectively ; P 0.01) and the curve (F l 8.25, P 0.000) for the CAD patients differed significantly from those of the controls (Figure 1, bottom panel) . The women with CAD had also higher 9 h AUICs [including AUICs adjusted for baseline concentrations of TGRL apoB-48 (19.9p2.3 and 11.5p1.9 mg:h −" :l −" respectively, P l 0.01) and for LDL cholesterol (19.2p2.2 and 11.7p 1.9 mg:h −" :l −" respectively, P 0.05)], PIC and time to peak concentration (4.87p0.21 and 4.33p0.14 h respectively, P 0.05) compared with controls ( Table 2) .
The AUICs were similar in the subjects with and without beta-blocker medication (20.7p2.8 and 22.3p 6.3 mg:h −" :l −" respectively).
Effects of hormone replacement therapy
The controls with and without post-menopausal hormone replacement therapy had similar postprandial 9 h AUICs for triacylglycerols (5.17p0.63 and 5.15p 0.55 mmol:h −" :l −" respectively) and apoB-48 (10.8p Postprandial lipaemia in female coronary heart disease Table 4 Correlations between postprandial AUIC values for the TGRL fraction and baseline parameters in all subjects (n l 54)
AUICs were calculated under 24 h incremental curves, except for triacylglycerols and apoB-48, for which 9 h-incremental curves were used. Significance of correlations : *P 0.05 ; **P 0.01 ; ***P 0.001. 
Correlations
The fasting apoB-48 level was significantly correlated with the concentrations of squalene (r l 0.71), triacylglycerols (r l 0.63) and cholesterol (r l 0.58) in the TGRL fraction. Basal serum triacylglycerols, TGRL squalene and VLDL cholesterol were positively correlated with the postprandial AUICs of triacylglycerols, squalene, retinyl palmitate and apoB-48 in the TGRL fraction ( Table 4 ). The postprandial AUIC for TGRL apoB-48 was also correlated positively with the fasting concentrations of TGRL apoB-48 and LDL cholesterol. The AUICs for squalene and apoB-48 were significantly correlated with the AUICs for triacylglycerols (r l 0.72 and r l 0.61 respectively) and retinyl palmitate (r l 0.82 and r l 0.53 respectively) in the TGRL fraction. The higher the fasting serum and LDL cholesterol and squalene concentrations, the higher were the squalene AUICs in TGRL or in chylomicrons.
DISCUSSION
The present study shows for the first time that postmenopausal women with angiographically demonstrated CAD without hormone replacement therapy have altered postprandial metabolism of squalene and apoB-48 in the TGRL fraction as compared with healthy control women matched for age and body mass index. The findings extend a previous study, which demonstrated that the apoB-48 level only in postprandial IDL particles was abnormally high in women with CAD compared with controls with valvular heart disease [15] . Other major findings of the present study were that postprandial VLDL accumulated in women with CAD, and that hormone replacement therapy did not affect the postprandial metabolism of squalene, apoB-48 and retinyl palmitate in healthy post-menopausal women. Squalene could label postprandial lipoproteins with higher specificity than vitamin A, since the squalene AUICs were higher for chylomicrons and VLDL in women with CAD. In addition, postprandial squalene in d 1.006 lipoprotein peaked earlier than retinyl palmitate, and had returned to normal at 24 h, in both groups. A greater postprandial rise in intestinally derived lipoproteins could be attributed either to effective and prolonged intestinal absorption of lipids or to their retarded clearance. Lipoprotein lipase hydrolyses triacylglycerols of large chylomicrons or VLDL particles, followed by hepatic catabolism of the resulting remnants. The similar triacylglycerol responses in the plasma and chylomicrons in the women with CAD and the controls after the fat meal suggest that the subjects with CAD are unlikely to have delayed fat absorption or inefficient lipolytic activity. Identical postprandial 4 h curves of apoB-48 in the CAD and control groups (Figure 1 , bottom panel) suggest that the formation of intestinal lipoproteins was similar. The higher postprandial AUICs in the CAD group were mostly accounted for by the increased areas under the 4-24 h curves for squalene and the 4-9 h curves for apoB-48 (Figure 1 ). Thus it can be inferred that the clearance of intestinally derived lipoproteins is diminished in women with CAD. Lipoprotein lipase activity appears to be similar in women with and without CAD [15] , but chylomicrons and VLDL particles compete for the same lipolytic activity [27] . Oestrogens may up-regulate hepatic LDL receptors [28] and result in the rapid clearance of intestinal lipoproteins [29, 30] , whereas progestin, in contrast with oestrogen, enhances hepatic lipase activity [31] . The present study showed no effect of hormone replacement therapy (oestrogen in the presence or absence of progestin), in agreement with a previous study [32] .
The diminished postprandial clearance of lipoproteins in the women with CAD was strongly substantiated by the responses of squalene and apoB-48, weakly by that of retinyl palmitate, and insignificantly by that of triacylglycerol. Patients with CAD have been shown to exhibit similar postprandial chylomicron triacylglycerol AUICs, but higher retinyl palmitate AUIC responses of chylomicron remnants, in a case control follow-up study [13] . On the other hand, similar AUICs for chylomicron retinyl palmitate and TGRL apoB-48, but higher respective chylomicron triacylglycerol values, have been demonstrated previously in women with CAD compared with controls [15] . As intestinal particles are hydrolysed before hepatic uptake and are mixed with endogenous VLDL or its remnants, the ability of postprandial triacylglycerols to label intestinal lipoproteins should be considered carefully. Postprandial responses of squalene and retinyl palmitate were correlated significantly with each other in the TGRL fraction, similar to earlier studies [19] . However, in d 1.006 lipoproteins, which also contain remnants of IDL density, postprandial squalene peaked almost 3 h earlier than retinyl palmitate (Figure 1 ; P 0.001). In contrast with the retinyl palmitate levels, the 24 h postprandial concentration of squalene had returned to baseline in both groups, and in postprandial lipoproteins the concentration of squalene was more frequently increased than that of retinyl palmitate in the women with CAD, indicating that squalene may be a better marker than vitamin A for intestinally derived lipoproteins.
More rapid attainment of peak postprandial triacylglycerol and apoB-48 concentrations compared with those of squalene and retinyl palmitate (Figure 1) suggests that the absorption of squalene and vitamin A is slower than that of fat. In addition, squalene and retinyl esters, in contrast with triacylglycerols, remain in the chylomicrons and chylomicron remnants until hepatic uptake occurs. Consequently, lipoprotein particles of intestinal origin should become triacylglycerol-depleted and squalene-and retinyl ester-enriched in the later phases of the postprandial period. In fact, the squalene\ triacylglycerol and, in particular, retinyl palmitate\ triacylglycerol ratios were clearly higher in chylomicrons than in the VLDL fractions, probably due in part to hepatic VLDL, indicating that, in proportion to triacylglycerols, the two markers accumulated mainly in chylomicrons throughout the postprandial period (Table 3) . On the other hand, the earlier peaking of squalene and retinyl palmitate concentrations in chylomicrons compared with VLDL in the control subjects only suggested that VLDL particles appeared more rapidly in the circulation of the CAD women than of the controls. Thus chylomicrons were converted rapidly into VLDL remnants, or the latter were secreted directly from the intestine, as has been shown previously [33, 34] .
The magnitude of postprandial lipaemia is usually associated with basal lipid and lipoprotein levels [35] [36] [37] . Although the postprandial AUICs for squalene and apoB-48 were positively associated with their baseline concentrations, adjusted AUICs for the fasting values were still significantly higher in the women with CAD than in the controls. In addition, the possible confounding effects of diabetes [38] , obesity [39] , smoking [40] and apoE phenotype distribution [41, 42] on postprandial lipaemia were avoided in the present study, because these parameters were similar in the two groups. The subjects with CAD taking beta-blocker medication tended to have lower postprandial AUICs for squalene and apoB-48 ; thus, among the non-users, the CAD patients showed higher postprandial responses than the controls.
ApoB-48 is essential for the synthesis of intestinally derived lipoproteins, and the circulating pool of this protein is regulated by the intestine, depending on fat intake. Biliary lipids, intestinal fatty acid uptake and the microsomal triacylglycerol content of mucosal cells actually regulate intestinal apoB-48 synthesis in rats [43] . Elevated apoB-48 concentrations in humans could also be explained by increased apoB mRNA editing activity [44] . Interestingly, in the present study the fasting apoB-48 concentration was strongly correlated with the squalene concentration in the TGRL fraction. The increased fasting squalene concentration in the women with CAD could not be explained by the higher LDL cholesterol level, because the squalene\cholesterol ratio was also increased. Whether this depends on enhanced cholesterol synthesis or altered metabolism of squalene should be shown by further non-cholesterol sterol and sterol balance studies.
In summary, the retarded postprandial clearance of lipoproteins and squalene, particularly of VLDL density, in women with CAD may have significant implications for the development of CAD in women.
